Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clearbridge BioPhotonics is a medical technology company specializing in advanced computational imaging for the life sciences and clinical diagnostics sectors. The company leverages Fourier Ptychographic Microscopy (FPM) technology, originally developed at the California Institute of Technology (Caltech), to provide high-resolution, wide-field digital imaging solutions. Its flagship product, the ClearScope system, enables high-throughput automated microscopy that can be integrated into existing pathology workflows. By digitizing traditional microscopy with superior depth of field and resolution, the company aims to enhance diagnostic precision in oncology and other therapeutic areas. The technology allows for slide-free imaging of thick tissue samples, potentially reducing the time and cost associated with traditional histology. Clearbridge BioPhotonics operates as a subsidiary of Clearbridge Health, focusing on the commercialization of next-generation digital pathology tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clearbridge BioPhotonics.